Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed Aug 6, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 105
- +8 vs. Q4 2023
- Portfolio value
- $5.67B
- +$1.20B (+26.8%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NUVLNuvalent, Inc. | COM | 2,783,454 | $209.0M | 3.7% | −134,537−4.6% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 3,933,556 | $273.6M | 4.8% | −611,253−13.4% | Reduced | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 19,272,991 | $285.6M | 5.0% | +7,293,576+60.9% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 28,057,456 | $330.5M | 5.8% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 10,794,876 | $456.3M | 8.0% | −170,317−1.6% | Reduced | History |
Options (7)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| IRONDisc Medicine, Inc. | COM | $18.7M | – |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $4.77M |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $4.74M | – |
| APLTApplied Therapeutics, Inc. | COM | – | $3.40M |
| NVAXNovavax Inc | COM NEW | $3.35M | – |
| IMVTImmunovant, Inc. | COM | – | $3.23M |
| AGIOAgios Pharmaceuticals, Inc. | COM | – | $2.92M |
Sold out since Q4 2023 (16)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| LIANYLianBio | SPONSORED ADS | 57,558,451 | $257.3M | 5.8% | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 4,024,400 | $95.1M | 2.1% | History |
| RYZBRayzeBio, Inc. | COM | 744,056 | $46.3M | 1.0% | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 132,176 | $16.6M | 0.4% | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 534,942 | $15.8M | 0.4% | History |
| TNGXTango Therapeutics, Inc. | COM | 1,111,870 | $11.0M | 0.2% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 539,831 | $7.57M | 0.2% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,075,000 | $6.98M | 0.2% | History |
| RGNXREGENXBIO Inc. | COM | 342,408 | $6.15M | 0.1% | History |
| TVTXTravere Therapeutics, Inc. | COM | 400,000 | $3.60M | 0.1% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 101,000 | $3.16M | 0.1% | History |
| CYTKCytokinetics Inc | COM NEW | 30,317 | $2.53M | 0.1% | History |
| KRONKronos Bio, Inc. | COM | 1,752,745 | $2.19M | <0.1% | History |
| AMAMAmbrx Biopharma, Inc. | COM | 78,811 | $1.12M | <0.1% | History |
| CYPHCypherpunk Technologies Inc. | COM NEW | 44,971 | $186.4K | <0.1% | History |
| BCABBioAtla, Inc. | COM | 73,000 | $179.6K | <0.1% | History |